In January 2024, a short squeeze of the stock of the American video game retailer GameStop (NYSE: GME) and other securities took place, causing major financial consequences for certain hedge funds and large losses for short sellers. Approximately 140 percent of GameStop's public float had been sold short, and the rush to buy shares to cover those positions as the price rose caused it to rise even further. The short squeeze was initially and primarily triggered by users of the subreddit Spletpred toliko dnevi: 2 · Most short interest money is tied up in Coinbase, with short interest of $2.71 billion, followed by CarMax with $1.8 billion shorted, GameStop with $1.32 billion, …
GameStop Corp. (GME) Stock Forum & Discussion - Yahoo Finance
SpletGME was never going bankrupt this year. The console cycle always spikes their stock for 6 months and Ryan Cohen began a takeover that sparked investor interest. If they had … Splet29. sep. 2024 · The short squeeze ‘claims’ from the mainstream media were that of only 20% gains. As this lid pops open, we can expect gains to run between 100%+ during intraday trading. This is how you will know the short squeeze has commenced. We would need to keep an eye out on the short interest and shares on loan. This is basically our ‘fuel’. marinhealth locations
Shorts Interest has declined again : r/gme_meltdown
Splet10. apr. 2024 · Short selling GME is an investing strategy that aims to generate trading profit from GameStop as its price is falling. GME shares are trading down $0.43 today. To … SpletAvg. daily volume has been more like 80-100M since late March, so days-to-cover is even lower. There is really no chance that this thing will do a meaningful squeeze. Fuck me, even Kenny cannot keep up with the dilution. Needs to buy a few more of these fancy synthetic shares printers. Splet07. jul. 2024 · The one thing missing here is Naked Shorting, and Short Exempt. In a situation where Naked Shorts flood the market of a stock and are all bought up, and those buyers hold long, this can lead to a situation where shorts (hedge funds and market makers) cannot cover the cost to repurchase all of the synthetics along with the needed legitimate … marin health login